Across TCGA pan-cancer cohorts, CCDC179 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated CCDC179 data layer.
The strongest signal is observed in uveal melanoma (UVM), where higher CCDC179 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CCDC179 expression acts as an unfavorable survival marker, although some lineages such as KIRC and SCLC show a favorable association.
UVM, LUSC, and DLBC are the cancer types where CCDC179 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.